Amphastar Pharmaceuticals AMPH Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Finished Pharmaceutical Products | $171.17M— | —— | $191.84M+10.0% | $174.41M+2.3% | $170.53M— | |
| Pharmaceutical Products | $171.17M— | —— | —— | —— | $170.53M— | |
| Revenue by Geography | ||||||
| CN | $2.48M+168% | $925K-50.8% | $1.88M+528% | $299K+269% | $81K-96.3% | |
| FR | $9.65M-9.2% | $10.63M+9.8% | $9.68M+36.1% | $7.11M-9.5% | $7.86M-15.0% | |
| US | $159.04M-7.3% | $171.55M-4.8% | $180.28M+8.0% | $167M+2.7% | $162.59M-7.1% | |
| Non-Current Assets by Geography | ||||||
| CN | $108.56M-1.4% | $110.06M+0.4% | $109.64M-0.7% | $110.41M-0.1% | $110.48M+2.4% | |
| FR | $35.32M-4.5% | $36.97M+0.2% | $36.89M-1.1% | $37.29M+6.6% | $34.99M+1.7% | |
| US | $235.03M+13.7% | $206.7M-0.1% | $207M0.0% | $207.03M-0.6% | $208.3M+2.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Amphastar Pharmaceuticals break its business down?
- Amphastar Pharmaceuticals (AMPH) reports revenue by business across 2 parts — Finished Pharmaceutical Products and Pharmaceutical Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Amphastar Pharmaceuticals's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Amphastar Pharmaceuticals's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
